Company intelligence / Profile preview

AA Pharma

Vaughan, Ontario, Canada

Ownership: Private
Employees: ~25
Development stage: Other

Overview

AA Pharma is an active Canadian pharmaceutical company specializing in legacy (well-established) small molecule drugs across more than 50 products and multiple therapeutic areas. Its products have proven efficacy, known safety profiles, are widely distributed across Canadian wholesalers and pharmacies, and primarily target well-established indications. Clinical results are referenced as established by years of real-world experience and head-to-head studies, rather than ongoing clinical trials[1][2][3].

Therapeutic areas: Other
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

Lithmax

Unknown

Partnerships

Apotex

Beyond the preview

Go deeper on AA Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AA Pharma.

Explore the full profile